½ÃÀ庸°í¼­
»óǰÄÚµå
1602155

¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå : À¯Çü, ¼ÒÀç, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Surgical Suture Market by Type (Monofilament Sutures, Multifilament Sutures), Material (Absorbable, Non-Absorbable), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 48¾ï ´Þ·¯·Î, 2024³â¿¡´Â 50¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.67%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 70¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿Ü°ú¿ë ºÀÇÕ»ç´Â ºÎ»óÀ̳ª ¼ö¼ú ÈÄ Á¶Á÷À» ºÀÇÕÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ÀÇ·á±â±¸·Î Èí¼ö¼º, ºñÈí¼ö¼º, õ¿¬, ÇÕ¼º µî ´Ù¾çÇÑ ÇüÅ·ΠÁ¦°øµÇ¾î ´Ù¾çÇÑ ÀÇ·á ¼ö¿ä¸¦ ÃæÁ·½Ãŵ´Ï´Ù. ¼ö¼ú¿ë ºÀÇÕ»çÀÇ Çʿ伺Àº °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϸ鼭 »óó Ä¡À¯¸¦ ÃËÁøÇÏ°í »óó Ä¡À¯¸¦ ÃËÁøÇÏ´Â ¸ðµç ¼ö¼ú¿¡ ³Î¸® »ç¿ëµÇ´Â °ÍÀ¸·ÎºÎÅÍ ¾Ë ¼ö ÀÖ½À´Ï´Ù. ºÀÇÕ»ç´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿¡¼­ »ç¿ëµÇ¸ç ÀÏ¹Ý ¿Ü°ú, Á¤Çü¿Ü°ú, ½ÉÇ÷°ü ¿Ü°ú, ºÎÀΰú µî ´Ù¾çÇÑ Àü¹® ºÐ¾ß¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀåÀº ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇÑ ¼ö¼ú °Ç¼ö Áõ°¡, ºÀÇÕ»ç Àç·áÀÇ ¹ßÀü, ȯÀÚ Áß½É Ä¡·áÀÇ Á߿伺 Áõ°¡ µî ÁÖ¿ä ¼ºÀå ¿äÀο¡ ÀÇÇØ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ´Â °¨¿° ¹æÁö¿Í Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Ç×±Õ ºÀÇÕ»ç ¹× »ýºÐÇØ¼º ºÀÇÕ»ç °³¹ß¿¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷Àº ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ¿© ºÎÀÛ¿ëÀ» ÁÙÀ̸鼭 Ä¡À¯¸¦ ÃËÁøÇÏ´Â »õ·Î¿î ¼ÒÀ縦 °³¹ßÇØ¾ß ÇÕ´Ï´Ù. ÇѰèÁ¡À¸·Î´Â °í±Þ ºÀÇÕ»çÀÇ ³ôÀº ºñ¿ë, ½ºÅ×ÀÌÇÃÀ̳ª Á¢ÂøÁ¦¿Í °°Àº »óó ºÀÇÕ ±â¼úÀÇ ´ëüǰ°úÀÇ Ä¡¿­ÇÑ °æÀï µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀ¸·Î ÀÎÇØ Á¦Ç° ½ÂÀÎ ¹× ½ÃÀå ÁøÀÔÀÌ Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù. ¼ö¼ú ÀýÂ÷ÀÇ º¹ÀâÇÑ Æ¯¼º°ú ¼ö¼ú¿ë Á¦Ç°ÀÇ Ç°Áú¿¡ ´ëÇÑ ¾ö°ÝÇÑ ¸ð´ÏÅ͸µÀº ½ÃÀå ¿ªÇÐÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. °¡Àå ¶Ù¾î³­ Çõ½Å ºÐ¾ß´Â Ä¡À¯¸¦ ¸ð´ÏÅ͸µÇÏ°í ¾à¹°À» ±¹¼ÒÀûÀ¸·Î Àü´ÞÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â ½º¸¶Æ® ºÀÇÕ»ç °³¹ßÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿ÍÀÇ Á¦ÈÞ¸¦ ÅëÇØ ƯÁ¤ ½Ã¼ú¿¡ ¸Â°Ô ºÀÇÕ Å°Æ®¸¦ ¸ÂÃãÈ­Çϰí, Àú·ÅÇÑ Á¦Ç°À¸·Î ½ÅÈï ½ÃÀåÀ» °ø·«Çϰí, ¿Ü°ú Àǻ翡°Ô ºÀÇÕ ±³À° ¹× Áö¿øÀ» Á¦°øÇÏ´Â µðÁöÅÐ ¼Ö·ç¼ÇÀ» ÃßÁøÇÔÀ¸·Î½á ºñÁî´Ï½º ¼ºÀåÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­ÇÏÁö¸¸, ±â¼ú ¹ßÀü°ú Àü·«Àû Á¦ÈÞ¸¦ ¿ì¼±½ÃÇÏ´Â ±â¾÷¿¡°Ô´Â ÀáÀç·ÂÀÌ ³ÑÃij³´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 48¾ï ´Þ·¯
¿¹Ãø³â[2024] 50¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 70¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 5.67%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤ ¹× »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°è ¿Ü°ú¼ö¼ú °Ç¼ö Áõ°¡
    • ȯÀÚÀÇ ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ºÇâ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿øÀÚÀç ºñ¿ë º¯µ¿°ú Á¦Ç° ¸®ÄÝ ¹ß»ý
  • ½ÃÀå ±âȸ
    • ¼ö¼ú¿ë ºÀÇÕ»ç »ý»ê¿¡ »ç¿ëµÇ´Â Àç·áÀÇ ¹ßÀü
    • ½º¸¶Æ® ºÀÇÕ»ç °³¹ß Áß½Ã
  • ½ÃÀå °úÁ¦
    • ´ëüǰÀÇ °¡¿ë¼º ¹× ¼ö¼ú¿ë ºÀÇÕ»ç¿Í °ü·ÃµÈ °¨¿° À§Ç輺

Porter's Five Forces: ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼­°ø±Þ¾÷ü ½ÇÀû Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå : À¯Çüº°

  • ¸ð³ëÇʶó¸àÆ® ºÀÇÕ»ç
  • ¸ÖƼ Çʶó¸àÆ® ºÀÇÕ»ç

Á¦7Àå ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå : ¼ÒÀ纰

  • Èí¼ö¼º
    • õ¿¬
      • Catgut
      • À籸¼º Äݶó°Õ
    • ÇÕ¼º
      • Monocryl
      • Polydioxanone
      • Vicryl
  • ºñÈí¼ö¼º
    • õ¿¬
      • ¼­ÁöÄà ÄÚÆ°
      • ¼­ÁöÄà ½ÇÅ©
      • ¼­ÁöÄà ö°­
    • ÇÕ¼º
      • Ethilon
      • Æú¸®ÇÁ·ÎÇÊ·»

Á¦8Àå ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå : ¿ëµµº°

  • ½ÉÀåÇ÷°ü ¿Ü°ú
  • ¹Ì¿ë¼ºÇü¿Ü°ú
  • ÀÏ¹Ý ¿Ü°ú
  • ºÎÀΰú ¼ö¼ú
  • ¾È°ú ¼ö¼ú
  • Á¤Çü¿Ü°ú

Á¦9Àå ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ŭ¸®´Ð°ú ¾à±¹
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿Ü°ú¿ë ºÀÇÕ»ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Able Medical Devices Inc.
  • Lotus Surgicals Pvt Ltd
  • Riverpoint Medical
  • Zimmer Biomet Holdings, Inc.
  • Advanced Medical Solutions Group plc
  • Lux Sutures SA
  • Healthium Medtech Ltd.
  • AIP Medical SA
  • Dolphin Sutures
  • Corza Medical GmbH
  • GMD Group
  • Atramat by Internacional Farmaceutica S.A . de C.V.
  • Centenial Surgical Suture Ltd.
  • McKesson Medical-Surgical Inc.
  • Vitrex Medical A/S
  • SUTUREGARD Medical, Inc.
  • Mellon Medical B.V.
  • B. Braun SE
  • Smith & Nephew PLC
  • Unisur Lifecare Pvt. Ltd.
  • Teleflex Incorporated
  • Shandong Haidike Medical Products Co.,Ltd.
  • AD Surgical
  • Johnson & Johnson Services, Inc.
  • Stryker Corporation
  • Medtronic PLC
  • Peters Surgical
  • Lydus Medical
  • DemeTECH Corporation
  • Orion Sutures India Pvt Ltd
  • Genesis Medtech
  • Sutumed Corp.
  • CONMED Corporation
  • Demophorius Healthcare Ltd.
KSA 24.12.10

The Surgical Suture Market was valued at USD 4.80 billion in 2023, expected to reach USD 5.08 billion in 2024, and is projected to grow at a CAGR of 5.67%, to USD 7.07 billion by 2030.

Surgical sutures are critical medical devices used to sew tissues together after an injury or surgery, coming in various forms such as absorbable and non-absorbable, natural and synthetic, catering to different medical requirements. The necessity of surgical sutures is underlined by their widespread use in all surgical procedures, promoting wound healing while minimizing infection risks. Sutures find application in hospitals, clinics, and ambulatory surgical centers, and their end-use spans various specialties including general surgery, orthopedics, cardiovascular, gynecology, and others. The surgical suture market is shaped by key growth factors such as an increasing number of surgeries due to the rising geriatric population, advancements in suture materials, and a growing emphasis on patient-centric care. The latest potential opportunities lie in the development of antimicrobial and biodegradable sutures, driven by heightened awareness of infection control and sustainability. To capitalize on these opportunities, firms should invest in R&D to innovate novel materials that enhance healing while reducing adverse reactions. Limitations include high costs of advanced sutures and intense competition from alternative wound closure technologies like staples and adhesives. Moreover, stringent regulatory requirements can also delay product approvals and market entry. The complex nature of surgical procedures and heightened scrutiny regarding surgical product quality further complicate market dynamics. The best innovation areas focus on creating smart sutures that can monitor healing and deliver drugs locally, providing enhanced patient outcomes. Business growth can be accelerated by pursuing partnerships with healthcare providers to customize suture kits for specific procedures, targeting emerging markets with affordable products, and advancing digital solutions that provide suture training and support for surgeons. The market is competitive yet layered with possibilities for firms that prioritize technological advancements and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 4.80 billion
Estimated Year [2024] USD 5.08 billion
Forecast Year [2030] USD 7.07 billion
CAGR (%) 5.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Surgical Suture Market

The Surgical Suture Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of surgical procedures globally
    • Patient inclination toward minimally invasive procedures
  • Market Restraints
    • Volatility of raw material cost and incidences of product recall
  • Market Opportunities
    • Advances in materials used for manufacturing surgical sutures
    • Significant emphasis on development of smart sutures
  • Market Challenges
    • Availability of alternatives and risk of infections associated with surgical suture

Porter's Five Forces: A Strategic Tool for Navigating the Surgical Suture Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Surgical Suture Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Surgical Suture Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Surgical Suture Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Surgical Suture Market

A detailed market share analysis in the Surgical Suture Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Surgical Suture Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Surgical Suture Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Surgical Suture Market

A strategic analysis of the Surgical Suture Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Surgical Suture Market, highlighting leading vendors and their innovative profiles. These include Able Medical Devices Inc., Lotus Surgicals Pvt Ltd, Riverpoint Medical, Zimmer Biomet Holdings, Inc., Advanced Medical Solutions Group plc, Lux Sutures SA, Healthium Medtech Ltd., AIP Medical SA, Dolphin Sutures, Corza Medical GmbH, GMD Group, Atramat by Internacional Farmaceutica S.A . de C.V., Centenial Surgical Suture Ltd., McKesson Medical-Surgical Inc., Vitrex Medical A/S, SUTUREGARD Medical, Inc., Mellon Medical B.V., B. Braun SE, Smith & Nephew PLC, Unisur Lifecare Pvt. Ltd., Teleflex Incorporated, Shandong Haidike Medical Products Co.,Ltd., AD Surgical, Johnson & Johnson Services, Inc., Stryker Corporation, Medtronic PLC, Peters Surgical, Lydus Medical, DemeTECH Corporation, Orion Sutures India Pvt Ltd, Genesis Medtech, Sutumed Corp., CONMED Corporation, and Demophorius Healthcare Ltd..

Market Segmentation & Coverage

This research report categorizes the Surgical Suture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Monofilament Sutures and Multifilament Sutures.
  • Based on Material, market is studied across Absorbable and Non-Absorbable. The Absorbable is further studied across Natural and Synthetic. The Natural is further studied across Catgut and Reconstituted Collagen. The Synthetic is further studied across Monocryl, Polydioxanone, and Vicryl. The Non-Absorbable is further studied across Natural and Synthetic. The Natural is further studied across Surgical Cotton, Surgical Silk, and Surgical Steel. The Synthetic is further studied across Ethilon and Polypropylene.
  • Based on Application, market is studied across Cardiovascular Surgery, Cosmetic & Plastic Surgery, General Surgery, Gynecological Surgery, Ophthalmic Surgery, and Orthopedic Surgery.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics & Dispensaries, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of surgical procedures globally
      • 5.1.1.2. Patient inclination toward minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Volatility of raw material cost and incidences of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in materials used for manufacturing surgical sutures
      • 5.1.3.2. Significant emphasis on development of smart sutures
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternatives and risk of infections associated with surgical suture
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: High adoption of monofilament sutures provides a lower risk of infection
    • 5.2.2. Material: Significant penetration of natural absorbable sutures
    • 5.2.3. Application: Proliferating utilization of surgical sutures in general surgeries
    • 5.2.4. End-User: Potential need for surgical sutures in the hospital sectors cater to multiple surgical specialties
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Surgical Suture Market, by Type

  • 6.1. Introduction
  • 6.2. Monofilament Sutures
  • 6.3. Multifilament Sutures

7. Surgical Suture Market, by Material

  • 7.1. Introduction
  • 7.2. Absorbable
    • 7.2.1. Natural
      • 7.2.1.1. Catgut
      • 7.2.1.2. Reconstituted Collagen
    • 7.2.2. Synthetic
      • 7.2.2.1. Monocryl
      • 7.2.2.2. Polydioxanone
      • 7.2.2.3. Vicryl
  • 7.3. Non-Absorbable
    • 7.3.1. Natural
      • 7.3.1.1. Surgical Cotton
      • 7.3.1.2. Surgical Silk
      • 7.3.1.3. Surgical Steel
    • 7.3.2. Synthetic
      • 7.3.2.1. Ethilon
      • 7.3.2.2. Polypropylene

8. Surgical Suture Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. Cosmetic & Plastic Surgery
  • 8.4. General Surgery
  • 8.5. Gynecological Surgery
  • 8.6. Ophthalmic Surgery
  • 8.7. Orthopedic Surgery

9. Surgical Suture Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Clinics & Dispensaries
  • 9.4. Hospitals

10. Americas Surgical Suture Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Surgical Suture Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Surgical Suture Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Suturion and Healthcare 21 Sign Exclusive Distributor Agreement
    • 13.3.2. Genesis MedTech secures China's NMPA Approval for Absorbable Sutures
    • 13.3.3. Riverpoint Medical Invests USD 10 Million In Its New Facilities And Manufacturing Site In The Coyol Free Trade Zone
    • 13.3.4. ZuriMED closes CHF 14.5 Million (USD16.6 million) Series A Round
    • 13.3.5. VESTECK, Inc. is excited to announce that the U.S. Patent Application No. 17/841,373 Title: REMOTE SURGICAL SUTURE SYSTEM, has been allowed by the U.S. Patent and Trademark Office (USPTO)
    • 13.3.6. Engineers Design Sutures that can Deliver Drugs or Sense Inflammation
    • 13.3.7. Stryker gets Medical Equipment to Regions in Need with Project C.U.R.E. Partnership
    • 13.3.8. Able Medical Announces Launch of Valkyrie Looped Sternotomy Sutures
    • 13.3.9. Lydus Medical Announces U.S. FDA Clearance of Microvascular Anastomosis Aid Device
    • 13.3.10. Stryker Launches Citrefix Suture Anchor System, Featuring Award-Winning Citregen Biomaterial Designed to Support Bone Regeneration and the Natural Healing Process
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Able Medical Devices Inc.
  • 2. Lotus Surgicals Pvt Ltd
  • 3. Riverpoint Medical
  • 4. Zimmer Biomet Holdings, Inc.
  • 5. Advanced Medical Solutions Group plc
  • 6. Lux Sutures SA
  • 7. Healthium Medtech Ltd.
  • 8. AIP Medical SA
  • 9. Dolphin Sutures
  • 10. Corza Medical GmbH
  • 11. GMD Group
  • 12. Atramat by Internacional Farmaceutica S.A . de C.V.
  • 13. Centenial Surgical Suture Ltd.
  • 14. McKesson Medical-Surgical Inc.
  • 15. Vitrex Medical A/S
  • 16. SUTUREGARD Medical, Inc.
  • 17. Mellon Medical B.V.
  • 18. B. Braun SE
  • 19. Smith & Nephew PLC
  • 20. Unisur Lifecare Pvt. Ltd.
  • 21. Teleflex Incorporated
  • 22. Shandong Haidike Medical Products Co.,Ltd.
  • 23. AD Surgical
  • 24. Johnson & Johnson Services, Inc.
  • 25. Stryker Corporation
  • 26. Medtronic PLC
  • 27. Peters Surgical
  • 28. Lydus Medical
  • 29. DemeTECH Corporation
  • 30. Orion Sutures India Pvt Ltd
  • 31. Genesis Medtech
  • 32. Sutumed Corp.
  • 33. CONMED Corporation
  • 34. Demophorius Healthcare Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦